Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection

Overview

Journal Microbiome

Publisher Biomed Central

Specialties Genetics
Microbiology

Date 2023 Mar 3

PMID 36869345

Authors

Jiarui Li

Qiuyu Jing

Jie Li

Mingxi Hua

Lin Di

Chuan Song

Yanyi Huang

Jianbin Wang

Chen Chen

Angela Ruohao Wu

Affiliations

Soon will be listed here.

Abstract

Background: The human microbiome plays an important role in modulating the host metabolism and immune system. Connections and interactions have been found between the microbiome of the gut and oral pharynx in the context of SARS-CoV-2 and other viral infections; hence, to broaden our understanding of host-viral responses in general and to deepen our knowledge of COVID-19, we performed a large-scale, systematic evaluation of the effect of SARS-CoV-2 infection on human microbiota in patients with varying disease severity.

Results: We processed 521 samples from 203 COVID-19 patients with varying disease severity and 94 samples from 31 healthy donors, consisting of 213 pharyngeal swabs, 250 sputa, and 152 fecal samples, and obtained meta-transcriptomes as well as SARS-CoV-2 sequences from each sample. Detailed assessment of these samples revealed altered microbial composition and function in the upper respiratory tract (URT) and gut of COVID-19 patients, and these changes are significantly associated with disease severity. Moreover, URT and gut microbiota show different patterns of alteration, where gut microbiome seems to be more variable and in direct correlation with viral load; and microbial community in the upper respiratory tract renders a high risk of antibiotic resistance. Longitudinally, the microbial composition remains relatively stable during the study period.

Conclusions: Our study has revealed different trends and the relative sensitivity of microbiome in different body sites to SARS-CoV-2 infection. Furthermore, while the use of antibiotics is often essential for the prevention and treatment of secondary infections, our results indicate a need to evaluate potential antibiotic resistance in the management of COVID-19 patients in the ongoing pandemic. Moreover, a longitudinal follow-up to monitor the restoration of the microbiome could enhance our understanding of the long-term effects of COVID-19. Video Abstract.

Citing Articles

The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.

Martin-Castano B, Diez-Echave P, Garcia-Garcia J, Hidalgo-Garcia L, Ruiz-Malagon A, Molina-Tijeras J Elife. 2025; 13.

PMID: 39963971 PMC: 11835386. DOI: 10.7554/eLife.95292.

Temporal Dynamics and (Para)Clinical Factors Associated With (Long) Viral RNA Shedding in COVID-19 Nonhospitalized Individuals - The COVID-HOME Study.

Vlaming-van Eijk L, Ertugrul I, Upasani V, Wold K, Vincenti-Gonzalez M, Veloo A J Med Virol. 2024; 96(12):e70125.

PMID: 39690930 PMC: 11653057. DOI: 10.1002/jmv.70125.

Association between gut microbiota and acute upper respiratory tract infection: a Mendelian randomization study.

Li Y, Chen G, Chen K, Li W, Chen Y Sci Rep. 2024; 14(1):29063.

PMID: 39580552 PMC: 11585582. DOI: 10.1038/s41598-024-80516-w.

Large-scale genetic correlation studies explore the causal relationship and potential mechanism between gut microbiota and COVID-19-associated risks.

Li H, Wen J, Zhang X, Dai Z, Liu M, Zhang H BMC Microbiol. 2024; 24(1):292.

PMID: 39103761 PMC: 11299294. DOI: 10.1186/s12866-024-03423-0.

Oropharyngeal Microbiome Analysis in Patients with Varying SARS-CoV-2 Infection Severity: A Prospective Cohort Study.

Siasios P, Giosi E, Ouranos K, Christoforidi M, Dimopoulou I, Leshi E J Pers Med. 2024; 14(4).

PMID: 38672996 PMC: 11051038. DOI: 10.3390/jpm14040369.

References

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L . Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(15):713-720. PMC: 7108196. DOI: 10.1093/cid/ciaa203. View

Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z . SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. 2020; 92(9):1676-1680. PMC: 7264521. DOI: 10.1002/jmv.25936. View

Mattison K, Wilbur J, So M, Brennan R . Structure of FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of toxin-antitoxin heterodimers containing pin domains and ribbon-helix-helix motifs. J Biol Chem. 2006; 281(49):37942-51. DOI: 10.1074/jbc.M605198200. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J . Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2021; 71(1):222-225. PMC: 8666823. DOI: 10.1136/gutjnl-2021-324090. View

Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

Kopylova E, Noe L, Touzet H . SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics. 2012; 28(24):3211-7. DOI: 10.1093/bioinformatics/bts611. View

Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L . Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 2021; 7(1):61. PMC: 8298611. DOI: 10.1038/s41522-021-00232-5. View

10.

Hanawa T, Yonezawa H, Kawakami H, Kamiya S, Armstrong S . Role of Bordetella pertussis RseA in the cell envelope stress response and adenylate cyclase toxin release. Pathog Dis. 2013; 69(1):7-20. PMC: 3844529. DOI: 10.1111/2049-632X.12061. View

11.

Li D, Liu C, Luo R, Sadakane K, Lam T . MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015; 31(10):1674-6. DOI: 10.1093/bioinformatics/btv033. View

12.

Smirnova E, Huzurbazar S, Jafari F . PERFect: PERmutation Filtering test for microbiome data. Biostatistics. 2018; 20(4):615-631. PMC: 6797060. DOI: 10.1093/biostatistics/kxy020. View

13.

Liu Q, Mak J, Su Q, Yeoh Y, Lui G, Ng S . Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022; 71(3):544-552. DOI: 10.1136/gutjnl-2021-325989. View

14.

Wong V, Levi K, Baddal B, Turton J, Boswell T . Spread of Pseudomonas fluorescens due to contaminated drinking water in a bone marrow transplant unit. J Clin Microbiol. 2011; 49(6):2093-6. PMC: 3122780. DOI: 10.1128/JCM.02559-10. View

15.

Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H . Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021; 70(7):1253-1265. PMC: 8042598. DOI: 10.1136/gutjnl-2020-323826. View

16.

Ju Y, An Q, Zhang Y, Sun K, Bai L, Luo Y . Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection. Drug Discov Today. 2021; 26(9):2190-2197. DOI: 10.1016/j.drudis.2021.05.014. View

17.

Wang J, Li F, Wei H, Lian Z, Sun R, Tian Z . Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med. 2014; 211(12):2397-410. PMC: 4235643. DOI: 10.1084/jem.20140625. View

18.

Dalile B, Van Oudenhove L, Vervliet B, Verbeke K . The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019; 16(8):461-478. DOI: 10.1038/s41575-019-0157-3. View

19.

Barik S, Sureka K, Mukherjee P, Basu J, Kundu M . RseA, the SigE specific anti-sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation-dependent ClpC1P2 proteolysis. Mol Microbiol. 2009; 75(3):592-606. DOI: 10.1111/j.1365-2958.2009.07008.x. View

20.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270):220-232. PMC: 7833295. DOI: 10.1016/S0140-6736(20)32656-8. View